[Elsevier] Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial

Fiscer Post time 2 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-21 11:44
Reward10points


Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    30


Return to the list